JENNIFER VERBICK: Open Payments
NPI 1841269628 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,619 in 83 payments from 15 companies in 2025. Trend: 2023 $1,236 · 2024 $1,058 · 2025 $1,619
Food & beverage: $1,619
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $291 |
| Novo Nordisk Inc | 7 | $233 |
| Novartis Pharmaceuticals Corporation | 20 | $231 |
| AstraZeneca Pharmaceuticals LP | 7 | $209 |
| PFIZER INC. | 11 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $94 |
| Abbott Laboratories | 3 | $80 |
| BridgeBio Pharma, Inc. | 2 | $65 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $51 |
Products named: LEQVIO, WINREVAIR, WAINUA, Ozempic, ELIQUIS, JARDIANCE, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, Wegovy.
Industry payments across OK — which companies pay providers there.
